JAMA Dermatology

<jats:p>This case report describes a patient with refractory porokeratosis ptychotropica who experienced substantial improvement in symptoms with upadacitinib treatment.</jats:p>

Treatment of porokeratosis ptychotropica with a topical combination of cholesterol and simvastatin.

JAMA Dermatol

Safety and efficacy of topical simvastatin plus cholesterol cream versus topical simvastatin cream alone for porokeratosis ptychotropica: a randomized, single-blind, split-body, placebo-controlled, investigator-initiated trial.

J Am Acad Dermatol

Genomic variations of the mevalonate pathway in porokeratosis.

Elife

Clonal expansion of second-hit cells with somatic recombinations or C&gt;T transitions form porokeratosis in MVD or MVK mutant heterozygotes.

J Invest Dermatol

The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch.

Cell

Targeted anti-interleukin-17 therapy for linear porokeratosis.

Br J Dermatol

This case report describes a patient with refractory porokeratosis ptychotropica who experienced substantial improvement in symptoms with upadacitinib treatment.

Treatment of Porokeratosis Ptychotropica With Upadacitinib.

Treatment of Porokeratosis Ptychotropica With Upadacitinib

Papers